Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson’s syndrome
- 23 March 2005
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 112 (10) , 1345-1353
- https://doi.org/10.1007/s00702-005-0281-9
Abstract
A G309D mutation in the PINK1 gene in a consanguineous Spanish kindred with seven siblings, three of whom are clinically affected, has recently been shown to be a cause of the PARK6 form of autosomal-recessive Parkinson’s syndrome. In this family, we studied pre- and postsynaptic dopaminergic function using 123I-FP-CIT- and 123I-iodobenzamide-SPECT to determine binding to the presynaptic dopamine transporter (DAT) and postsynaptic D2 receptors respectively. All three PARK6 patients showed reduced striatal DAT binding with posterior preponderance similar to sporadic idiopathic PD, but only one patient showed significant striatal asymmetry. In two of the siblings, DAT binding was markedly increased. IBZM-SPECT was normal in both patients and sibs. Our findings indicate that 123I-FP-CIT-SPECT shows similar DAT binding in PARK6 patients compared to idiopathic Parkinson’s disease. The increased DAT binding in heterozygous PARK6 carriers may be a new very early preclinical finding, but its significance is still unclear.Keywords
This publication has 28 references indexed in Scilit:
- Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1Science, 2004
- α‐Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's diseaseFEBS Letters, 2004
- Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorderPsychiatry Research: Neuroimaging, 2004
- Monoamine Transporters: From Genes to BehaviorAnnual Review of Pharmacology and Toxicology, 2003
- Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET studyAnnals of Neurology, 2002
- Park6‐linked parkinsonism occurs in several european familiesAnnals of Neurology, 2001
- Phenotypic characterisation of autosomal recessive PARK6‐linked parkinsonism in three unrelated Italian familiesMovement Disorders, 2001
- Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography studyAnnals of Neurology, 1997
- Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]RacloprideMovement Disorders, 1997